BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 23392293)

  • 1. Octreotide prophylaxis is not beneficial for biochemical activity and clinical severity of postoperative pancreatic fistula after pancreatic surgery.
    Droeser RA; Jeanmonod P; Schuld J; Moussavian MR; Schilling MK; Kollmar O
    Dig Surg; 2012; 29(6):484-91. PubMed ID: 23392293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized controlled study of the effect of octreotide on pancreatic exocrine secretion and pancreatic fistula after pancreatoduodenectomy.
    You DD; Paik KY; Park IY; Yoo YK
    Asian J Surg; 2019 Feb; 42(2):458-463. PubMed ID: 30262436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comment on the article by Droeser et al.: 'Octreotide prophylaxis is not beneficial for biochemical activity and clinical severity of postoperative pancreatic fistula after pancreatic surgery'.
    Büchler MW
    Dig Surg; 2013; 30(4-6):328-9. PubMed ID: 24051517
    [No Abstract]   [Full Text] [Related]  

  • 4. Randomized, placebo-controlled study of the efficacy of preoperative somatostatin administration in the prevention of postoperative complications following pancreaticoduodenectomy.
    Wang W; Tian B; Babu SR; Zhang Y; Yang M
    Hepatogastroenterology; 2013 May; 60(123):400-5. PubMed ID: 23178468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of low dose octreotide prophylaxis in pancreatic transplants with enteric drainage. Results of a prospective randomized single center trial.
    Hesse UJ; Meester D; Troisi R; Cathenis K; Lameire N; Hemptinne B
    Clin Transplant; 2005 Jun; 19(3):299-303. PubMed ID: 15877788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective study of prophylactic long-acting octreotide in high-risk patients undergoing pancreaticoduodenectomy.
    Graham JA; Johnson LB; Haddad N; Al-Kawas F; Carroll J; Jha R; Wong J; Maglaris D; Mertens S; Fishbein T
    Am J Surg; 2011 Apr; 201(4):481-5. PubMed ID: 21421102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective, randomized trial of Roux-en-Y reconstruction with isolated pancreatic drainage versus conventional loop reconstruction after pancreaticoduodenectomy.
    Ke S; Ding XM; Gao J; Zhao AM; Deng GY; Ma RL; Xin ZH; Ning CM; Sun WB
    Surgery; 2013 Jun; 153(6):743-52. PubMed ID: 23601899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pancreaticojejunal anastomotic stent: friend or foe?
    Sachs TE; Pratt WB; Kent TS; Callery MP; Vollmer CM
    Surgery; 2013 May; 153(5):651-62. PubMed ID: 23305594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of abdominal drainage in individual risk assessment of pancreatic fistula following pancreaticoduodenectomy.
    Ansorge C; Nordin JZ; Lundell L; Strömmer L; Rangelova E; Blomberg J; Del Chiaro M; Segersvärd R
    Br J Surg; 2014 Jan; 101(2):100-8. PubMed ID: 24306817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prospective and randomized study on the usefulness of octreotide in the prevention of complications after cephalic duodeno-pancreatectomy].
    Briceño Delgado FJ; López Cillero P; Rufián Peña S; Solórzano Peck G; Miño Fugarolas G; Pera Madrazo C
    Rev Esp Enferm Dig; 1998 Oct; 90(10):687-94. PubMed ID: 9824933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of intra-arterial octreotide on pancreatic texture: a randomized controlled trial.
    Belyaev O; Polle C; Herzog T; Munding J; Chromik AM; Meurer K; Tannapfel A; Bergmann U; Müller CA; Uhl W
    Scand J Surg; 2013; 102(3):164-70. PubMed ID: 23963030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective administration of prophylactic octreotide during pancreaticoduodenectomy: a clinical and cost-benefit analysis in low- and high-risk glands.
    Vanounou T; Pratt WB; Callery MP; Vollmer CM
    J Am Coll Surg; 2007 Oct; 205(4):546-57. PubMed ID: 17903728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors of pancreatic fistula following pancreaticoduodenectomy for periampullary cancer.
    Popiela T; Kedra B; Sierzega M; Gurda A
    Hepatogastroenterology; 2004; 51(59):1484-8. PubMed ID: 15362783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness comparison of prophylactic octreotide and pasireotide for prevention of fistula after pancreatic surgery.
    Welsch T; Müssle B; Distler M; Knoth H; Weitz J; Häckl D
    Langenbecks Arch Surg; 2016 Nov; 401(7):1027-1035. PubMed ID: 27233242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical impact of preoperative cholangitis after biliary drainage in patients who undergo pancreaticoduodenectomy on postoperative pancreatic fistula.
    Yanagimoto H; Satoi S; Yamamoto T; Toyokawa H; Hirooka S; Yui R; Yamaki S; Ryota H; Inoue K; Michiura T; Matsui Y; Kwon AH
    Am Surg; 2014 Jan; 80(1):36-42. PubMed ID: 24401513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatogastrostomy as a salvage procedure to treat severe postoperative pancreatic fistula after pancreatoduodenectomy.
    Bachellier P; Oussoultzoglou E; Rosso E; Scurtu R; Lucescu I; Oshita A; Jaeck D
    Arch Surg; 2008 Oct; 143(10):966-70; discussion 971. PubMed ID: 18936375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does prophylactic octreotide decrease the rates of pancreatic fistula and other complications after pancreaticoduodenectomy? Results of a prospective randomized placebo-controlled trial.
    Yeo CJ; Cameron JL; Lillemoe KD; Sauter PK; Coleman J; Sohn TA; Campbell KA; Choti MA
    Ann Surg; 2000 Sep; 232(3):419-29. PubMed ID: 10973392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic octreotide and delayed gastric emptying after pancreaticoduodenectomy: results of a prospective randomized double-blinded placebo-controlled trial.
    Kollmar O; Moussavian MR; Richter S; de Roi P; Maurer CA; Schilling MK
    Eur J Surg Oncol; 2008 Aug; 34(8):868-875. PubMed ID: 18299182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postoperative pancreatic fistula: We need to redefine grades B and C.
    Hackert T; Hinz U; Pausch T; Fesenbeck I; Strobel O; Schneider L; Fritz S; Büchler MW
    Surgery; 2016 Mar; 159(3):872-7. PubMed ID: 26603847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Octreotide in the prevention of intra-abdominal complications following elective pancreatic resection: a prospective, multicenter randomized controlled trial.
    Suc B; Msika S; Piccinini M; Fourtanier G; Hay JM; Flamant Y; Fingerhut A; Fagniez PL; Chipponi J;
    Arch Surg; 2004 Mar; 139(3):288-94; discussion 295. PubMed ID: 15006886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.